News &amp; Updates

Among older adults, frailty appears to aggravate the risk of hospital readmission after cardiac implantable electrical device (CIED) implantation, according to a recent study.

Single-dose psilocybin shows therapeutic potential in treatment-resistant depression

Administering a single dose of psilocybin results in a significant reduction in depression scores over a period of 3 weeks but at the expense of increased adverse effects, according to the results of a phase II trial.

Haloperidol of little benefit to ICU patients with delirium

Treatment with haloperidol falls short of improving survival in intensive care unit (ICU) patients who are experiencing delirium, as shown in a study.

Faecal matter transplantation is quickly transitioning into mainstream medicine with more research and evidence supporting its use.

Faecal matter transplantation (FMT) science is maturing and becoming increasingly accepted by the medical community, says an expert.

HKU programme offers free comprehensive genomic profiling tests to NSCLC patients

The University of Hong Kong (HKU) has launched a precision oncology programme in partnership with public and private stakeholders to provide free comprehensive genomic profiling tests to 1,800 eligible patients with stage IV non-small-cell lung cancer (NSCLC) in Hong Kong. Initial data from the programme revealed less common mutations amenable to treatment with targeted therapies in a sizeable proportion of patients.

14 Nov 2022

Early ART yields better outcomes in HIV

Early antiretroviral therapy (ART) in individuals with HIV offers better outcomes, particularly in those aged 35 years and younger, in a follow-up analysis of the START trial. Conversely, delayed therapy results in a higher risk of death and serious health issues in this population.

Prophylactic gastrostomy improves outcomes in head and neck cancer

Prophylactic percutaneous endoscopic gastrostomy (pPEG) can enhance nutrition outcomes, reduce treatment delay, and maintain quality of life (QoL) in patients with head and neck cancer (HNC), suggests a recent study.

Dolutegravir: A better choice for HIV viral suppression in pregnancy?

13 Nov 2022 by

Among pregnant individuals on antiretroviral therapy (ART) for HIV-1 infection, those on dolutegravir had the greatest viral suppression rates at delivery, a recent US-based observational study showed. However, birth outcomes generally did not differ between dolutegravir recipients and those on various other ART regimens.

13 Nov 2022

Polygenic risk scores predict response to ECT for major depressive disorder

A polygenic liability for major depressive disorder and bipolar disorder contributes to improvements following electroconvulsive therapy (ECT), reports a study. This provides evidence of a genetic factor for clinical response to ECT.

13 Nov 2022

Once-weekly semaglutide safe, effective in type 2 diabetes patients